PP
REPL icon

Paloma Partners’s Replimune Group REPL Stock Holding History

Paloma Partners’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-20,433
Closed -$293K – 1931
2019
Q4 		$293K Buy
+20,433
New +$294K ﹤0.01% 1770

Other funds holding REPL

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Paloma Partners's REPL Position: Q1 2020 in Review

Paloma Partners sold out of Replimune Group (REPL) in Q1 2020, closing a stake of 20,433 shares — an estimated $293K sold.

Paloma Partners first reported a position in REPL in Q4 2019 and held it in 1 quarter. The position peaked at $293K in Q4 2019. 56 funds tracked by Wall St. Rank hold REPL as of Q1 2020.

  • Paloma Partners reported no remaining Replimune Group position as of Q1 2020 after selling out during the quarter.
  • Paloma Partners sold 20,433 Replimune Group shares in Q1 2020, an estimated $293K.
  • Paloma Partners first reported a position in Replimune Group in Q4 2019 and held it in 1 quarter.
  • Paloma Partners's Replimune Group position peaked at $293K in Q4 2019.
  • 56 funds tracked by Wall St. Rank held Replimune Group as of Q1 2020.

Based on Paloma Partners's 13F filing for Q1 2020, filed 15 May 2020.